Alluvi BPC-157 + TB-500 40mg Pen

Alluvi BPC-157 + TB-500 40mg Pen is a dual-action research peptide formulation combining two highly studied compounds known for their role in tissue regeneration, recovery, and cellular repair pathways. This ready-to-use research pen format provides precision dosing for laboratory experiments involving musculoskeletal healing, peptide synergy, and regenerative biology studies.

BPC-157 (Body Protection Compound) has been studied for its influence on gut lining repair, soft tissue regeneration, and angiogenesis, while TB-500 (Thymosin Beta-4 fragment) has been linked to accelerated recovery, cellular growth, and inflammation reduction. When combined, the synergy offers a powerful research platform for studying advanced repair mechanisms.

Peptide Profile:

• Compounds: BPC-157 + TB-500 peptide blend
• Form: Pre-filled research pen
• Concentration: 40mg total
• Purity: ≥98%
• Use Case: Tissue repair, inflammation studies, cellular regeneration, musculoskeletal research

How to Use in Research:

• Typical study dose: 250–750mcg daily depending on research protocol
• Suggested administration: subcutaneous injection in experimental settings
• Designed for precision micro-dosing research formats
• Store refrigerated for stability and peptide preservation

Research Stacking Suggestions: Typically paired with NAD+, Semaglutide, or BPC-157 standalone testing in tissue recovery and regenerative trials.

For laboratory and scientific research use only — not for human consumption.